Dihydroquinidine: potential for treatment of short-QT syndrome?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1439, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitors: Do They Have Potential in the Treatment of Polycystic Ovary Syndrome?

By Kodaman Pinar H.

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1771-1785

Adis International

Access to resources Recommend Favorite

GLP-2 beneficial in functional short bowel syndrome?

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Nasal airway treatment worth it in sleep apnoea syndrome?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 411, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

New treatments for Tourette's syndrome?

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Reassessing the Benefits and Risks of Alosetron: What is its Place in the Treatment of Irritable Bowel Syndrome?

By Andresen V.

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite